Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-990-0
CAS number: 68937-40-6
Acute oral toxicity:2 key studiess: Acute toxic class method, Limit tests (according to EPA 43:163, 37336-37402 (1978), similar to OECD 401,1981): LD50 > 5000 mg/kg bw (male/female rat).Acute dermal toxicity:3 key studies: Standard acute method, Limit tests (according to EPA 43:163, 37336-37402 (1978), comparable to OECD 402): LD50 > 2000 mg/kg bw (male/female rabbit).Acute inhalation toxicity:1 key study: Standard acute method, Limit test (no guideline followed): LC50, 6h > 0.4 mg/L air (vaporized sample; male rat).
The two key studies for acute
oral toxicity were chosen as they were performed according to methods
similar to OECD guideline 401. In both studies 10 male and 10 female
rats; 10 male and 20 female rats, resp., were exposed to 5000 mg/kg bw
of the test substance and observed for 14 days. The LD50 (for both male
and female rats) was found to be > 5000 mg/kg bw.
Four supporting studies were
available. In two of these studies, the LD50 was also > 5000 mg/kg bw (5
male rats, and 10 males and 10 females resp.). In one study, no
guideline being followed, the LD50 was > 15800 mg/kg bw (2 male and 3
female rats), and in another supporting study, performed according to
methodology comparable to OECD guideline 423, the 14d-LD50 was > 5000
(male rats) and > 4700 mg/kg bw (female rats).
All studies support the
conclusion that tBuTPP is not acutely toxic via the oral route.
In the three available key
acute dermal toxicity tests of Phosflex 71B, Phosflex 72B, and Fyrquel
LT resp., 5 male and 5 female rabbits each were exposed to the test
substance for 24 hours and observed for 14 days. The LD50 (for both
males and females) was found to be > 2000 mg/kg bw in all 3 key studies.
Three supporting studies were
available that were not performed according to methods similar to an
OECD guideline. In one study the dermal LD50 (for both 5 males and 5
females) was found to be > 2000 mg/kg bw. In the other two supporting
studies (standard acute method; 2 male and 1 female rabbits tested) the
LD50 was > 7940 mg/kg bw.
All studies support the
conclusion that tBuTPP is not acutely toxic via the dermal route.
One key study concerning
acute inhalation toxicity study in rats is available. Six male rats were
exposed to Santicizer 154 at a concentration of 0.4 mg/l for 6 hours.
Signs of intoxication and mortality were observed during the observation
period of 14 days. No toxic signs were found. Viscera appeared normal.
No mortality occurred. Under the conditions of this test, the LC50 was
found to be > 0.4 mg/l for 6 h. In one available very concise supporting
report for acute inhalation toxicity 10 male and 10 female rats were
exposed to a fine-particle aerosol of Phosflex 51B for 4 hours at a mean
concentration of 3.1 mg/l. The LC50 was found to be > 3.1 mg/l for 4h.
For acute oral toxicity, the
LD50 value (for both male and female rats) was found to be > 5000 mg/kg
bw in both key studies. Based on this value and the criteria outlined in
Annex I of 1272/2008/EC and Annex VI of 67/548/EEC, the substance
t-BuTTP does not need to be classified for acute oral toxicity.
For acute dermal toxicity,
the LD50 value of > 2000 mg/kg bw was used for classification. Based on
this value and the criteria outlined in Annex I of 1272/2008/EC and
Annex VI of 67/548/EEC, the substance t-BuTTP does not need to be
classified for acute dermal toxicity.
For acute inhalation
toxicity, the LC50 value of > 0.4 mg/l for 6 h was used for
classification. Based on this value and according to the EU criteria
outlined in 67/548/EEC and 1272/2008/EC (CLP/EU-GHS) t-BuTTP does not
need to be classified and has no obligatory labelling requirement for
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again